background image
REF_N
CAS_N
NAME
SYNONIM
DIR
RESTRICTIONS
AND
SPECIFICATIONS
SCF
List
EFSA/SCF_OP
PL
CT
163
containing: a) 5,7-di-tert-
butyl-3-(3,4-
dimethylphenyl)-3H-
benzofuran-2-one (80 to
100% w/w) and b) 5,7-
di-tert-butyl-3-(2,3-
dimethylphenyl)-3H-
benzofuran-2-one (0 to
20% w/w)
46720
004130-42-1 2,6-Di-tert-butyl-4-
ethylphenol
DIR QMA = 4.8 mg/6 dmē
3
R: 0.8 mg/dmē.
Available: 3 negative mutagenicity studies,
90-day oral rat and dog studies,
bioaccumulation, calculation of the worst
case as well as analytical method.
(RIVM 93/6/3330/001, 1993-01-
26=CS/PM/2011, TNO 1995-04-
03=CS/PM/2580).
+
46750
000088-58-4 2,5-Di-tert-
butylhydroquinone
W
+
46790
004221-80-1 3,5-Di-tert-butyl-4-
hydroxybenzoic acid,
2,4-di-tert-butylphenyl
ester
Same 47200
DIR
2
TDI: 2 mg/kg bw.
90-day oral rat study.
(RIVM report May 1973).
+
+
46800
067845-93-6 3,5-Di-tert-butyl-4-
hydroxybenzoic acid,
hexadecyl ester
Same 58800
DIR
2
TDI: 2.5 mg/kg b.w.
90-day oral rat and dog studies, reproduction
study in rats, mutagenicity studies.
(RIVM doc. 88/678608/001, 1 November
1988).
+
46870
003135-18-0 3,5-Di-tert-butyl-4-
hydroxybenzylphosphoni
c acid, dioctadecyl ester
Same 49760
DIR
2
TDI: 1 mg/kg bw.
A 90-day oral rat study.
(CIBA-GEIGY report, 14 February 1970).
+
46880
065140-91-2 3,5-Di-tert-butyl-4-
hydroxybenzylphosphoni
c acid, monoethyl ester,
calcium salt
Same 41020
DIR SML = 6 mg/kg
2
TDI = 0.1 mg/kg b.w.
A 4+4 week, a 13+4 week and a two year
oral rat studies.
(Ciba-Geigy reports CBG 174/78110, 10-07-
1978 and CBG 192/781233, 22-03-1979,
CBG 261/821163, 4 April 1984).
+
+
46960
030947-30-9 3,5-Di-tert-butyl-4-
hydroxybenzylphosphoni
c acid, monoethyl ester,
8
+